InsightsLatest
Latest from Drip
Deep dives, recaps, weekly briefs, trends, and expert answers, newest first.
Deep dive
Europe’s Social Media Bans Spark Privacy Backlash
Europe’s tough new under-15 and under-16 social media bans are sparking a fierce privacy backlash as governments turn digital ID checks into the gateway for teens—and adults—online.

Deep dive
AI Squeezes Career Ladder, Women Bear the Brunt
As AI wipes out entry-level jobs, women in tech are being squeezed hardest—facing stalled careers, burnout, and shrinking authority at the very moment companies need fresh leadership most.
Deep dive
Holiday Scams Hit Record Highs as Fraud Goes Mainstream
Holiday scams have exploded into the mainstream, with digital fraud and fake sites hitting record highs as Americans rush through their 2026 holiday shopping.
Deep dive
Canton Network Powers DTCC’s Leap to Live Tokenized Trades
DTCC just vaulted from pilot to live production on Canton, setting a new standard for institutional-grade, privacy-first tokenized securities trading.
Deep dive
Depot Power, Not EVs, Now Stalls Fleet Electrification
Fleet electrification is no longer about buying more EVs—it's about supercharging depot infrastructure before the grid says 'no more.'
Deep dive
Freight Revenues Soar, But Diesel Devours Carrier Profits
Freight carriers are raking in record revenues thanks to soaring spot and intermodal rates—but runaway diesel and driver costs are devouring the profits before they hit the bottom line.
Deep dive
Yum! Surges on Q3 Beat Despite Taco Bell Outbreak Woes
Yum! Brands beat Q3 expectations and won over Wall Street—even as Taco Bell battled a major Cyclospora outbreak and the company hit the gas on its Pizza Hut exit and KFC reboot.

Deep dive
Prologis Powers Ahead: Data Centers, Deals Fuel Stock Surge
Prologis is flexing its industrial muscle, powering through an $18.8B Segro acquisition and a $5B stock offering while data center demand and leasing surges fuel a bullish stock run.
Deep dive
Xcel’s $6B Cash Surge Fuels Growth—and Investor Debate
Xcel Energy’s $6 billion cash raise has supercharged its growth ambitions—and sparked a fierce investor debate over dilution and risk.
Deep dive
ADP’s AI Gains Power Profits—But Skeptics Eye Risks
ADP’s profits are surging on the back of AI-fueled productivity and float income, but skeptics warn the rally may be fragile.
Deep dive
Creator Marketing Booms, But Brands Lose Control
Creator marketing is booming as brands like McDonald’s chase social relevance—but they’re losing message control and clarity on what really works.
Deep dive
David Jones Collapse: Legacy Retail Model Meets Digital Reality
David Jones’ 188-year run ended in dramatic collapse as its old-school department store model crumbled under the weight of missed digital bets and stubborn lease burdens.

Deep dive
Valve Revolution: TAVR Expands as Next-Gen Tech Gains Steam
Transcatheter valve therapy is breaking out of its last-resort box, surging into mainstream care and spawning a new wave of next-gen innovations.

Deep dive
Founder Succession Spurs Boom in CEO Advisory Services
Founder-CEO succession is no longer an afterthought—advisory giants are scrambling to help companies dodge leadership meltdowns before it’s too late.

Deep dive
AI Writes the Docs, Judgment Bottlenecks Product Teams
AI can draft your docs in seconds, but real progress now bottlenecks at human judgment, not keystrokes.
Trend
Validated Home Devices Are Winning the Blood Pressure and Diabetes Workflow
Clinically validated home devices are moving from optional monitoring tools to the default infrastructure for blood pressure and diabetes care. Reimbursement rules, transmission requirements, and clinical acceptance are steering demand toward devices that can reliably feed care workflows and support ongoing management. The next phase of growth will favor platforms that pair validated hardware with software, services, and reimbursement resilience.
Trend
WRAPSODY Registry Turns Outcomes Into Reimbursement Leverage
WRAPSODY’s registry is showing how post-market evidence can convert clinical performance into reimbursement leverage. By documenting strong patency and reintervention outcomes, the company can support payer confidence, provider adoption, and future label expansion. The broader market implication is that durable registry depth is becoming a commercial asset, not just a regulatory requirement.
Trend
Workflow and Uptime Become the New Procurement Layer
Medical device procurement is moving up the stack from hardware selection to operational performance. Providers increasingly want integrated ordering, fulfillment, maintenance, inventory visibility, and service response because decentralized care depends on reliable workflows and equipment uptime. That shift is creating new competitive advantage for vendors that can package devices with recurring services and prove better availability, faster response, and lower operational friction.
Trend
Virtuoso Turns Robotic Urology Into a Reimbursable Indication
Virtuoso’s De Novo authorization marks a shift from generic robotic surgery claims to indication-by-indication commercialization in urology. By tying robotic transurethral bladder surgery to en bloc resection and diagnostic tissue sampling, the company strengthens the case for reimbursement around measurable specimen quality. The broader market is moving toward platforms that can prove procedure-specific value, secure coverage, and drive recurring case volume.
Trend
Agentic AI Becomes an Operations Execution Layer
Agentic AI is emerging as the execution layer for enterprise operations, orchestrating multi-step workflows across finance, procurement, IT, supply chain, and customer service. The biggest value is faster cycle times and fewer manual handoffs, but scaling depends on governance, auditability, and human oversight for high-impact actions. The trend is moving from isolated automation toward controlled, end-to-end operational orchestration.